| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |